Evidence map›Paper›PMID 26030618›Full record

ArticlePloS one2015

Group B streptococcal infection and activation of human astrocytes.

Terri D Stoner, Thomas A Weston, JoAnn Trejo, Kelly S Doran

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 46 citations in OpenAlex.

  1. Re-framing the importance of Group BInfection and immunity · 2024
    Review
  2. Review
  3. Article
  4. Group BPathogens (Basel, Switzerland) · 2022
    Article
  5. Frontiers in cellular and infection microbiology · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Terri D StonerDepartment of Biology, Center for Microbial Sciences, San Diego State University, San Diego, CA, United States of America; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA, United States of America.
Thomas A WestonDepartment of Biology, Center for Microbial Sciences, San Diego State University, San Diego, CA, United States of America.
JoAnn TrejoDepartment of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA, United States of America.
Kelly S DoranDepartment of Biology, Center for Microbial Sciences, San Diego State University, San Diego, CA, United States of America; Departmant of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA, United States of America.
University of California, San Diego · USSan Diego State University · US

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Blood-brain barrier in bacterial meningitisR01NS051247 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORAN, KELLY S · 2006 to 2015
$3.2M
Mechanisms Regulating GPCR TraffickingR01GM090689 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2010 to 2018
$2.9M
NIGMS NIH HHS K12 GM068524NIGMS NIH HHS R01 GM090689NINDS NIH HHS R01 NS051247NINDS NIH HHS R01-NS051247
6 · The paper itself

Abstract

backgroundStreptococcus agalactiae (Group B Streptococcus, GBS) is the leading cause of life-threatening meningitis in human newborns in industrialized countries. Meningitis results from neonatal infection that occurs when GBS leaves the bloodstream (bacteremia), crosses the blood-brain barrier (BBB), and enters the central nervous system (CNS), where the bacteria contact the meninges. Although GBS is known to invade the BBB, subsequent interaction with astrocytes that physically associate with brain endothelium has not been well studied. METHODOLOGY/PRINCIPAL

findingsWe hypothesize that human astrocytes play a unique role in GBS infection and contribute to the development of meningitis. To address this, we used a well- characterized human fetal astrocyte cell line, SVG-A, and examined GBS infection in vitro. We observed that all GBS strains of representative clinically dominant serotypes (Ia, Ib, III, and V) were able to adhere to and invade astrocytes. Cellular invasion was dependent on host actin cytoskeleton rearrangements, and was specific to GBS as Streptococcus gordonii failed to enter astrocytes. Analysis of isogenic mutant GBS strains deficient in various cell surface organelles showed that anchored LTA, serine-rich repeat protein (Srr1) and fibronectin binding (SfbA) proteins all contribute to host cell internalization. Wild-type GBS also displayed an ability to persist and survive within an intracellular compartment for at least 12 h following invasion. Moreover, GBS infection resulted in increased astrocyte transcription of interleukin (IL)-1β, IL-6 and VEGF. CONCLUSIONS/SIGNIFICANCE: This study has further characterized the interaction of GBS with human astrocytes, and has identified the importance of specific virulence factors in these interactions. Understanding the role of astrocytes during GBS infection will provide important information regarding BBB disruption and the development of neonatal meningitis.

Indexed as

AstrocytesBacterial AdhesionHumansStreptococcal InfectionsStreptococcus agalactiae

Identifiers

PMID26030618
PMCPMC4452173
OpenAlexW632380799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.